WHO ICTRP trial
MEV90 Study of Ropivacaine Hydrochloride for Ultrasound-Guided Interscalene…
ChiCTR2400083266 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400083266 |
|---|---|
| Public title | MEV90 Study of Ropivacaine Hydrochloride for Ultrasound-Guided Interscalene Brachial Plexus Block in Patients Undergoing Shoulder Arthroscopy: A Prospective Dose-Finding Study |
| Scientific title | MEV90 Study of Ropivacaine Hydrochloride for Ultrasound-Guided Interscalene Brachial Plexus Block in Patients Undergoing Shoulder Arthroscopy: A Prospective Dose-Finding Study |
| Primary sponsor | Honghui Hospital, Xi'an Jiaotong University College of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Rotator Cuff Injury |
| Interventions | case series:Sequential method |
| Registration date | Apr 19, 2024 |
| Target size | case series:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: